Cargando…

Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors

Cardiovascular diseases (CVD) are a global health concern, affecting millions of patients worldwide and being the leading cause of global morbidity and mortality, thus creating a major public health concern. Sodium/glucose cotransporter 2 (SGLT2) inhibitors have emerged as a promising class of medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frąk, Weronika, Hajdys, Joanna, Radzioch, Ewa, Szlagor, Magdalena, Młynarska, Ewelina, Rysz, Jacek, Franczyk, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377079/ https://www.ncbi.nlm.nih.gov/pubmed/37509724 http://dx.doi.org/10.3390/biomedicines11072085

Ejemplares similares

New Insights into Molecular Mechanisms of Chronic Kidney Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
por: Dąbek, Bartłomiej, et al.
Publicado: (2023)

Cellular Mechanisms of Coronary Artery Spasm
por: Franczyk, Beata, et al.
Publicado: (2022)

Advances in the Pathogenesis and Treatment of Resistant Hypertension
por: Dybiec, Jill, et al.
Publicado: (2023)

Molecular Interactions of Arterial Hypertension in Its Target Organs
por: Kućmierz, Joanna, et al.
Publicado: (2021)

Pathophysiology of Cardiovascular Diseases: New Insights into Molecular Mechanisms of Atherosclerosis, Arterial Hypertension, and Coronary Artery Disease
por: Frąk, Weronika, et al.
Publicado: (2022)

Chronic Kidney Disease as a Comorbidity in Heart Failure
por: Szlagor, Magdalena, et al.
Publicado: (2023)

Structural and Functional Changes in Aging Kidneys
por: Dybiec, Jill, et al.
Publicado: (2022)

New Insights into the Nephroprotective Potential of Lercanidipine
por: Hajdys, Joanna, et al.
Publicado: (2023)

The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
por: Kowalska, Klaudia, et al.
Publicado: (2022)

Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
por: Krzemińska, Julia, et al.
Publicado: (2022)

New Insights into the Use of Empagliflozin—A Comprehensive Review
por: Forycka, Joanna, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists—Use in Chronic Kidney Disease
por: Baran, Wiktoria, et al.
Publicado: (2021)

Novel Insights into the Molecular Mechanisms of Atherosclerosis
por: Wojtasińska, Armanda, et al.
Publicado: (2023)

New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
por: Wronka, Magdalena, et al.
Publicado: (2023)

Advances in Treatment of Dyslipidemia
por: Dybiec, Jill, et al.
Publicado: (2023)

What Is the Role of Gut Microbiota in Obesity Prevalence? A Few Words about Gut Microbiota and Its Association with Obesity and Related Diseases
por: Tokarek, Julita, et al.
Publicado: (2021)

Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
por: Tokarek, Julita, et al.
Publicado: (2023)

The Influence of SARS-CoV-2 Infection on Lipid Metabolism—The Potential Use of Lipid-Lowering Agents in COVID-19 Management
por: Kowalska, Klaudia, et al.
Publicado: (2022)

Arterial Hypertension—Oxidative Stress and Inflammation
por: Krzemińska, Julia, et al.
Publicado: (2022)

Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19
por: Młynarska, Ewelina, et al.
Publicado: (2022)

The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes
por: Wronka, Magdalena, et al.
Publicado: (2022)

Empagliflozin—A New Chance for Patients with Chronic Heart Failure
por: Kowalska, Klaudia, et al.
Publicado: (2021)

Acute Kidney Injury in COVID-19
por: Głowacka, Marta, et al.
Publicado: (2021)

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
por: Młynarska, Ewelina, et al.
Publicado: (2022)

Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure
por: Tokarek, Julita, et al.
Publicado: (2023)

Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
por: Fularski, Piotr, et al.
Publicado: (2023)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021)

Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease
por: Bartnicki, Piotr, et al.
Publicado: (2016)

Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
por: Rysz, Jacek, et al.
Publicado: (2020)

Diabetes and Cardiovascular Risk in Renal Transplant Patients
por: Rysz, Jacek, et al.
Publicado: (2021)

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2018)

The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022)

High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk Factors
por: Koziarska-Rościszewska, Małgorzata, et al.
Publicado: (2021)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

Are Alterations in DNA Methylation Related to CKD Development?
por: Rysz, Jacek, et al.
Publicado: (2022)

The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease
por: Gluba-Sagr, Anna, et al.
Publicado: (2023)

miRNA biomarkers in renal disease
por: Franczyk, Beata, et al.
Publicado: (2021)

Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
por: Franczyk, Beata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ale1c24ou9t5fnd793kiq8n2v4